Squarepoint’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
Squarepoint's STIM Position: Q3 2026 in Review
Squarepoint increased its Neuronetics (STIM) stake by 361% in Q3 2026, buying an estimated $838K and bringing the position to 435,951 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2763.
Squarepoint first reported a position in STIM in Q3 2019 and has held it in 15 quarters since. 24 funds tracked by Wall St. Rank hold STIM as of Q3 2026.
- Squarepoint held 435,951 shares of Neuronetics worth $1.02M as of Q3 2026.
- Squarepoint bought 341,335 Neuronetics shares in Q3 2026, an estimated $838K.
- Neuronetics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #2763 holding.
- Squarepoint first reported a position in Neuronetics in Q3 2019 and has held it in 15 quarters since.
- 24 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.